二氢叶酸还原酶
化学
效力
抗菌活性
抗菌剂
组合化学
甲氧苄啶
芳基
结构-活动关系
细菌
抗生素
立体化学
微生物学
生物化学
体外
酶
生物
有机化学
烷基
遗传学
作者
Xiaoming Li,M.T. Hilgers,Mark L. Cunningham,Zhiyong Chen,Michael Trzoss,Junhu Zhang,Lucy Kohnen,Thanh Lam,Chris Creighton,G. C. Kedar,Kirk J. Nelson,Bryan P. Kwan,Mark A. Stidham,Vickie Brown‐Driver,Karen Joy Shaw,John Finn
标识
DOI:10.1016/j.bmcl.2011.07.059
摘要
Dihydrofolate reductase (DHFR) inhibitors such as trimethoprim (TMP) have long played a significant role in the treatment of bacterial infections. Not surprisingly, after decades of use there is now bacterial resistance to TMP and therefore a need to develop novel antibacterial agents with expanded spectrum including these resistant strains. In this study, we investigated the optimization of 2,4-diamnoquinazolines for antibacterial potency and selectivity. Using structure-based drug design, several 7-aryl-2,4-diaminoquinazolines were discovered that have excellent sub-100 picomolar potency against bacterial DHFR. These compounds have good antibacterial activity especially on gram-positive pathogens including TMP-resistant strains.
科研通智能强力驱动
Strongly Powered by AbleSci AI